SCHEMBL5616029

SCHEMBL5616029

CCCCCN1CCC2(CC1)CN(C(=O)c1ccc([N+](=O)[O-])o1)c1ccc(F)cc12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
KMT2A Q03164 5/20 0.38
ALDH1A1 P00352 4/20 0.38
MITF O75030 4/20 0.38
MAPT P10636 4/20 0.38
HTT P42858 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
RAB9A P51151 2/20 0.38
LMNA P02545 1/20 0.38
ADRB2 P07550 1/20 0.38
STING1 Q86WV6 1/20 0.36
NPSR1 Q6W5P4 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 1/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
PAX8 Q06710 1/20 0.35
SLC2A1 P11166 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5579081 0.85 ALDH1A1 (0.38) KMT2AALDH1A1MITFMAPTHTT
SCHEMBL5578886 0.81 SLC18A3 (0.45) SLC18A3SIGMAR1KMT2AALDH1A1MAPT
SCHEMBL5814543 0.76 SIGMAR1 (0.46) SLC18A3SIGMAR1LMNA
SCHEMBL5616027 0.76 SIGMAR1 (0.43) SLC18A3SIGMAR1KMT2AALDH1A1MAPT
SCHEMBL5616199 0.76 SIGMAR1 (0.43) SLC18A3SIGMAR1
SCHEMBL5615760 0.75 SIGMAR1 (0.43) SLC18A3SIGMAR1
SCHEMBL5578540 0.73 SLC18A3 (0.46) SLC18A3SIGMAR1
SCHEMBL5578618 0.73 SIGMAR1 (0.46) SLC18A3SIGMAR1
SCHEMBL5578855 0.72 SIGMAR1 (0.44) SLC18A3SIGMAR1
SCHEMBL5578456 0.72 HTR2A (0.49) SLC18A3SIGMAR1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005063745-A9 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARM INC (US) 2007-02-01 WO disclosed
EP-1716148-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF Arena Pharmaceuticals, Inc. (US) 2006-11-02 EP disclosed
WO-2005063745-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARMACEUTICALS, INC. (US) 2005-07-14 WO disclosed